In this context, under pathological conditions in which Th17 cells trigger an autoimmune disease, the dysregulated enhancement mediated by the amplifier may be induced by unchecked activation of NF-κB and/or STAT3 in fibroblasts via a variety of environmental and/or genetic factors [86]. This evidence concerns the gene NFKB1 and autoimmune disease.